Prognostic Score in Covid-19
Completed
- Conditions
- Covid19 Prognostic Parameters
- Interventions
- Other: data collection
- Registration Number
- NCT04780373
- Lead Sponsor
- University of L'Aquila
- Brief Summary
The aim of the study is to define the clinical and biochemical parameters that characterize COVID-19 patients with a negative prognostic evolution. Our clinical score will be capable to recognize patient with favorable prognosis or patient with poor prognosis by statistical data analysis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- patients over 18 and symptomatic and positive for COVID-19 by polymerase chain reaction assay for rhino-pharingeal swab
Exclusion Criteria
- Under 18
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Validation cohort data collection - Development cohort data collection -
- Primary Outcome Measures
Name Time Method Data collection of clinical and demographical parameters of patients affected by COVID-19 8 months Data about sex, age, symptom start date, vital parameters, comorbidity, symptoms, hematochemicals blood tests, therapy, oxygen support, radiology, condition evaluation will be manual collected.
- Secondary Outcome Measures
Name Time Method Application of statistical analysis on data of patients affected by COVID-19 2 months The collected data will be analyzed through descriptive statistics analysis, ROC curves, regression analysis, and Machine Learning techniques to predict the prognosis of patients affected by COVID-19.
Trial Locations
- Locations (1)
University of L'Aquila
🇮🇹L'Aquila, Italy